Psilocybin glossary: terms from calculators, lab reports and studies
Short, sourced definitions of the words that turn up on dosage calculator pages, batch lab reports and psilocybin research papers. None of them includes an amount to take, because no definition can tell you what's in a particular mushroom.

How to use this glossary
Terms are grouped by first letter; tap a letter to jump. Each definition names the study, rule or agency behind its facts, numbered to the sources at the end. For the chemistry in more depth, read psilocybin vs psilocin; for lab reports, see what the mg on a capsule label means.
0-9
- 4-AcO-DMT
- 4-acetoxy-N,N-dimethyltryptamine, a synthetic relative of psilocin. Colorado treats any 4-AcO-DMT in a natural medicine product as a failed test.1 Six of 8 mushroom gummies bought at Portland, Oregon smoke and vape shops contained it.2
- 5-HT2A receptor
- A serotonin receptor in the brain. Psilocin produces psychedelic effects by acting on it.3 See receptor occupancy.
A
B
- Baeocystin
- Psilocybin with one fewer methyl group (4-phosphoryloxy-N-methyltryptamine), first described in 1968 from Psilocybe baeocystis.5 Without its phosphate it becomes norpsilocin.6
- Batch (or lot)
- A quantity of product made or harvested together and tested as one unit. Oregon tests every batch for potency, and Colorado tests each harvest lot.7, 1 A lab report covers only the batch it names.
- Bluing
- The blue color where a psilocybin mushroom is bruised: the mushroom's enzymes turn psilocybin into psilocin and oxidize it into blue chains.8 A 1982 study of 20 species found no correlation between bluing and psilocybin or psilocin levels.9
C
- Certificate of analysis (COA)
- A lab's report on a sample from one batch: lab, batch number, dates, compounds, method, units and results. In Oregon, the product information document that goes with each product must include its potency test results.7 See capsule labels for questions to ask of one.
- Cmax
- The peak concentration a drug reaches in the blood. A 2025 review reported that one trial found no correlation between psilocin Cmax and body weight, BMI or age.10
- Colorado natural medicine program
- Colorado's state-regulated system. Its Natural Medicine Division licenses healing centers, manufacturers and testing facilities, and listed 11 standard and 36 micro healing centers as of October 16, 2026.11 Sessions take place with a licensed facilitator, at a licensed healing center or another location the rules authorize;1 psilocybin remains illegal under federal law.12
- Contraindication
- A condition or medicine that makes a treatment inadvisable. Research safety guidelines flag a personal or family history of psychotic disorders, and chronic lithium or tricyclic antidepressant use.13 See who should avoid psilocybin.
- Cross-tolerance
- Tolerance to one drug that carries over to another. In a 1961 study of 19 volunteers, people made tolerant to LSD were "to a considerable degree, also cross tolerant to psilocybin", and the reverse.14
- Cubensis
- Short for Psilocybe cubensis, the only species Oregon's licensed program allows.7 A 2026 study compared 14 of its named strains under identical conditions.15
D
- Decriminalization
- Reducing penalties or making enforcement a low priority without making a drug legal. Denver's 2019 Initiated Ordinance 301 made adult personal use and possession of psilocybin mushrooms the city's "lowest law-enforcement priority"; psilocybin stayed illegal.16
- Dry weight
- A result stated per gram of dried material, the basis of most potency data on this site. Oregon tells labs not to adjust compliance results for moisture.17
F
- Fireside Project
- A free, confidential psychedelic peer support line: call or text 62-FIRESIDE (623-473-7433), 11 a.m. to 11 p.m. Pacific every day. It isn't a suicide hotline; for emergencies it directs people to 911, and for suicidal thoughts to 988.18
- Fixed dose
- Giving every trial participant the same amount regardless of body weight. A pooled analysis of 288 people found weight didn't predict the strength of effects.19
- Flush
- One wave of mushrooms from a culture. In a 1982 study of P. cubensis, psilocin was generally absent in the first flushes and highest by the fourth, while psilocybin showed no trend.20
G
H
- Half-life
- The time it takes for a drug's blood level to fall by half. For free psilocin, published studies report averages from 1.23 to 4.72 hours.10
- Homogenized
- Ground and mixed into one uniform powder so a test sample represents the batch. Oregon has labs homogenize a composite of whole mushrooms before testing.17
- HPPD
- Hallucinogen persisting perception disorder: persisting, distressing reoccurrence of drug-like perceptions after a hallucinogen. In controlled studies with 142 healthy people, 13 reported reoccurring drug-like experiences; none met the criteria for HPPD.22
L
- Limit of detection (LOD)
- The smallest amount a lab method can reliably detect, so a result below it means "not detected", not zero. In the 14-strain study, norpsilocin and norbaeocystin were mostly below it.15
- Lithium
- A mood stabilizer. Of 62 online reports of lithium combined with a classic psychedelic, 47% described seizures and 39% involved medical attention.23 Don't stop or change lithium without your prescriber; see the interaction reference.
M
- MAOI
- Monoamine oxidase inhibitor, a class of antidepressants. True serotonin toxicity typically follows a serotonergic drug overdose, or a serotonin-raising drug combined with an MAOI.24
- MEQ30
- The 30-item revised Mystical Experience Questionnaire, used in psilocybin studies to rate mystical-type experiences. It was validated with pooled data from 184 participants in five lab studies.25
- Microdose
- The research term for a sub-perceptual amount: one meant to be too small to change perception noticeably. A 2024 review of 19 placebo-controlled studies concluded "it is not yet possible to determine whether microdosing is a placebo."26 See microdosing research.
N
- Norbaeocystin
- A psilocybin relative with no methyl groups on its nitrogen (4-phosphoryloxytryptamine), described alongside baeocystin in 1968.5 Colorado's required lab panel includes it.1
- Norpsilocin
- 4-hydroxy-N-methyltryptamine, the dephosphorylated form of baeocystin, first reported as a natural product of P. cubensis in 2017.6
O
P
- Placebo
- An inactive substance given in place of the drug so researchers can separate drug effects from expectation. In a microdosing study completed by 191 people, the placebo group improved too, with no significant difference between groups.28
- Poison Control
- The national Poison Help line, 1-800-222-1222, which connects callers to their local poison center 24/7 in over 100 languages.29
- Prodrug
- A compound the body converts into the active drug. Psilocybin is a prodrug of psilocin: after it's swallowed, it is "rapidly absorbed and transformed to psilocin".10
- Psilocin
- 4-hydroxy-N,N-dimethyltryptamine, the active compound.30 It oxidizes easily, which is why bruised mushrooms turn blue.8 Federal law spells it "psilocyn".12
- Psilocybin
- 4-phosphoryloxy-N,N-dimethyltryptamine, the phosphate-carrying form stored in the mushroom.30 The phosphate protects it from oxidation until an enzyme removes it.8
- Psilocybin equivalent
- Psilocybin plus 1.4 times psilocin: a total in psilocybin terms. Oregon's draft rules call it "the maximum theoretical concentration of psilocybin in the sample". New Mexico's proposed labels require a "total psilocybin equivalent" too, but its rule doesn't give a formula.31, 32
R
- Receptor occupancy
- The share of a receptor type that a drug is bound to. In a PET study of 8 volunteers, psilocybin produced dose-related 5-HT2A occupancy up to 72%, and intensity correlated with both occupancy and blood psilocin.33
S
- Schedule I
- The federal schedule that lists psilocybin and psilocyn among hallucinogenic substances (21 CFR 1308.11(d)).12 State programs in Oregon and Colorado don't change federal law.
- Sclerotia
- Hardened masses of fungal tissue sold as "magic truffles" or "philosopher's stones". A 2013 study detected only psilocybin in them, measured on a fresh-weight basis.34
- Self-blinding
- A study design in which participants follow instructions to mix their own substance with placebo capsules, so they don't know which they're taking. In a 2021 microdosing study, participants guessing correctly could explain the small differences from placebo.28
- Serotonin syndrome
- The most severe form of serotonin toxicity. Signs needing immediate medical attention include muscle jerking, rigidity, high fever, extreme or swinging vital signs, agitation and seizures: call 911.24
- Set and setting
- Mindset (mood, expectations, intentions) and environment. In pooled data from 261 volunteers, sessions involving PET scanning predicted anxiety more strongly than dose did.35
- SSRI
- Selective serotonin reuptake inhibitor, an antidepressant class. In a survey, about half of reports of taking mushrooms with an SSRI described weaker effects.36 Don't stop an SSRI on your own.
- Strain
- A named line within a mushroom species. There's no comprehensive genetic reference for strain names, and in 14 P. cubensis strains grown the same way, psilocybin varied 9.66-fold.15
T
- Tolerance
- A weaker response to a drug after recent use. A 1961 study showed tolerance to psilocybin developed in volunteers, to a lesser degree than tolerance to LSD.14 See tolerance calculators for what's known about recovery.
- Total psilocin
- Psilocin plus 0.719 times psilocybin, a total in psilocin terms. Colorado labels call it "Total Psilocin";1 Oregon calls it "total potential psilocin", "the maximum theoretical concentration of psilocin in the sample".17
- Total tryptamines
- The sum of psilocybin, psilocin and relatives such as baeocystin, norbaeocystin, aeruginascin and norpsilocin. In the 14-strain study, totals differed 7.88-fold between strains.15
Sources
- 1 CCR 213-1, Natural Medicine Rules (Rules 1025, 3305, 4010, 4015, 7015, 8005, 8030), current version, including emergency rules effective August 12, 2026. Colorado Department of Revenue, Natural Medicine Division, retrieved October 26, 2026.
- Correia MS, et al. Quantitative analysis of recreational psychoactive mushroom gummies in Portland, Oregon. Clin Toxicol, 2025;63(4):261-266. PMID 39977248.
- Thomann J, et al. In vitro and in vivo metabolism of psilocybin's active metabolite psilocin. Front Pharmacol, 2024;15:1391689. PMID 38741590.
- Jensen N, Gartz J, Laatsch H. Aeruginascin, a trimethylammonium analogue of psilocybin from the hallucinogenic mushroom Inocybe aeruginascens. Planta Med, 2006;72(7):665-666. PMID 16673333.
- Leung AY, Paul AG. Baeocystin and norbaeocystin: new analogs of psilocybin from Psilocybe baeocystis. J Pharm Sci, 1968;57(10):1667-1671. PMID 5684732.
- Lenz C, Wick J, Hoffmeister D. Identification of omega-N-methyl-4-hydroxytryptamine (norpsilocin) as a Psilocybe natural product. J Nat Prod, 2017;80(10):2835-2838. PMID 28929753.
- Oregon Administrative Rules chapter 333, division 333 (psilocybin): OAR 333-333-2015, -2110, -2400, -2410, -7020, -7040, -7090, -7100. Oregon Secretary of State, retrieved October 26, 2026.
- Lenz C, et al. Injury-triggered blueing reactions of Psilocybe "magic" mushrooms. Angew Chem Int Ed, 2020;59(4):1450-1454. PMID 31725937.
- Beug MW, Bigwood J. Psilocybin and psilocin levels in twenty species from seven genera of wild mushrooms in the Pacific Northwest, U.S.A. J Ethnopharmacol, 1982;5(3):271-285. PMID 7201053.
- Otto ME, et al. Clinical pharmacokinetics of psilocin after psilocybin administration: a systematic review and post-hoc analysis. Clin Pharmacokinet, 2025;64(1):53-66. PMID 39812743.
- Natural Medicine Division home page and license counts. Colorado Department of Revenue, retrieved October 26, 2026.
- 21 CFR 1308.11, Schedule I, paragraph (d) hallucinogenic substances: (29) psilocybin, (30) psilocyn. Electronic Code of Federal Regulations, current as of October 23, 2026.
- Johnson MW, Richards WA, Griffiths RR. Human hallucinogen research: guidelines for safety. J Psychopharmacol, 2008;22(6):603-620. PMID 18593734.
- Isbell H, Wolbach AB, Wikler A, Miner EJ. Cross tolerance between LSD and psilocybin. Psychopharmacologia, 1961;2:147-159. PMID 13717955. Abstract text via the Erowid reference record.
- Sharchaton A, et al. Surprising variability in tryptamine profiles of Psilocybe cubensis fruiting bodies: inter- and intra-strain differences across 14 strains. J Fungi, 2026;12(7):486. PMID 42506248.
- Denver, Colorado, Psilocybin Mushroom Initiative, Initiated Ordinance 301 (May 2019). Ballotpedia, checked October 26, 2026.
- Oregon Administrative Rules chapter 333, division 64 (accreditation of laboratories, including psilocybin testing): OAR 333-064-0025, -0140, -0150. Oregon Secretary of State, retrieved October 26, 2026.
- Fireside Project. The Psychedelic Support Line. Checked October 26, 2026.
- Garcia-Romeu A, et al. Optimal dosing for psilocybin pharmacotherapy: considering weight-adjusted and fixed dosing approaches. J Psychopharmacol, 2021;35(4):353-361. PMID 33611977.
- Bigwood J, Beug MW. Variation of psilocybin and psilocin levels with repeated flushes (harvests) of mature sporocarps of Psilocybe cubensis. J Ethnopharmacol, 1982;5(3):287-291. PMID 7201054.
- Manevski N, et al. Glucuronidation of psilocin and 4-hydroxyindole by the human UDP-glucuronosyltransferases. Drug Metab Dispos, 2010;38(3):386-395. PMID 20007669.
- Müller F, et al. Flashback phenomena after administration of LSD and psilocybin in controlled studies with healthy participants. Psychopharmacology, 2022;239(6):1933-1943. PMID 35076721.
- Nayak SM, et al. Classic psychedelic coadministration with lithium, but not lamotrigine, is associated with seizures: an analysis of online psychedelic experience reports. Pharmacopsychiatry, 2021;54(5):240-245. PMID 34348413.
- Malcolm B, Thomas K. Serotonin toxicity of serotonergic psychedelics. Psychopharmacology, 2022;239(6):1881-1891. PMID 34251464.
- Barrett FS, Johnson MW, Griffiths RR. Validation of the revised Mystical Experience Questionnaire in experimental sessions with psilocybin. J Psychopharmacol, 2015;29(11):1182-1190. PMID 26442957.
- Polito V, Liknaitzky P. Is microdosing a placebo? A rapid review of low-dose LSD and psilocybin research. J Psychopharmacol, 2024;38(8):701-711. PMID 38877715.
- Oregon Psilocybin Services program page. Oregon Health Authority, retrieved October 26, 2026.
- Szigeti B, et al. Self-blinding citizen science to explore psychedelic microdosing. eLife, 2021;10:e62878. PMID 33648632.
- Poison Help, 1-800-222-1222. Health Resources and Services Administration, checked October 26, 2026.
- PubChem compound records: psilocybin (CID 10624) and psilocin (CID 4980). National Library of Medicine, retrieved October 26, 2026.
- Oregon Health Authority. Draft OAR 333-333 for the November 2026 Rules Advisory Committee, October 2026; planned effective date January 15, 2027 per the OHA psilocybin rules page.
- New Mexico Department of Health. Proposed rule 7.35.2 NMAC, Medical Psilocybin Producer and Laboratory Requirements (exhibits and rule text). 2026.
- Madsen MK, et al. Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels. Neuropsychopharmacology, 2019;44(7):1328-1334. PMID 30685771.
- Pellegrini M, et al. Magic truffles or Philosopher's stones: a legal way to sell psilocybin? Drug Test Anal, 2013;5(3):182-185. PMID 22887928.
- Studerus E, et al. Prediction of psilocybin response in healthy volunteers. PLoS One, 2012;7(2):e30800. PMID 22363492.
- Gukasyan N, et al. Attenuation of psilocybin mushroom effects during and after SSRI/SNRI antidepressant use. J Psychopharmacol, 2023;37(7):707-716. PMID 37291890.
Keep reading
Psilocybin vs psilocin: what's the difference?One is the stored form, the other the active one: the chemistry behind lab reports and blue bruises.
What does the mg on a mushroom capsule label mean?Powder weight, psilocybin or total psilocin? How to read a label and the batch lab report behind it.
Psilocybin potency: every magic mushroom lab measurement we could findPsilocybin measured in mushrooms, from 42 published sources, shown as ranges, with a free dataset to download.
Written and checked by the Dosage Calculator editors. Every figure on this page links to its source. Found an error? Tell us and we'll correct it in the open, as our editorial standards describe. Magic Mushroom Dosage Calculator is published by the team that runs My Mushroom Dispensary, an online shop. We sell no advertising and nothing on this site.